Craft

Histogenics

Revenue

$42.6 K

FY, 2020

Histogenics Summary

Company Summary

Overview
Histogenics is a company focused on developing products that meaningfully improve the lives of patients with defects in cartilage and joints. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually or in concert to treat musculoskeletal-related conditions.
Type
Subsidiary
Status
Closed
Founded
2000
HQ
Waltham, MA, US | view all locations
Website
http://www.histogenics.com/
Cybersecurity rating
Sectors

Key People

  • Adam Gridley

    Adam Gridley, President and Chief Executive Officer

    • E. Lynne Kelley

      E. Lynne Kelley, Chief Medical Officer

      • Jon Lieber

        Jon Lieber, CFO

        • Caroline Dugopolski

          Caroline Dugopolski, VP of Technical Operations

          LocationsView all

          3 locations detected

          • Waltham, MA HQ

            United States

            830 Winter St

          • Lexington, MA

            United States

            60 Westview St

          • Needham, MA

            United States

          Histogenics Financials

          Summary Financials

          Net income (Q3, 2022)
          ($21.9M)
          Cash (Q3, 2022)
          $101.6M
          EBIT (Q3, 2022)
          ($23.1M)

          Footer menu